Therapeutic targeting of the NLRP3 inflammasome using a potent and orally active inhibitor in experimental MND (2015–2016)

Grant type:
Motor Neurone Disease Research Institute of Australia Inc
Researchers:
Funded by:
Motor Neurone Disease Research Institute of Australia Inc